Obesity

Latest News

First Issue of Patient Care Online Digital Edition Goes Live
First Issue of Patient Care Online Digital Edition Goes Live

March 12th 2024

The inaugural digital issue of Patient Care focuses on the antiobesity and type 2 diabetes medications, semaglutide and tirzepatide.

Semaglutide 2.4 mg (Wegovy) Wins Expanded Indication to Include Reduced Risk of MACE / image credit overweight heart risk: ©CLIPAREA/shutterstock.com
Semaglutide 2.4 mg (Wegovy) Wins Expanded Indication to Include Reduced Risk of MACE

March 8th 2024

Novo Nordisk Shares Early Findings for Novel Oral Antiobesity Agent / image credit Novo logo ©JHVE photo/stock.adobe.com
Novo Nordisk Shares Early Findings for Novel Oral Antiobesity Agent

March 7th 2024

Semaglutide Shows Potential for Significant CVD Prevention: Daily Dose / image credit: ©New Africa/AdobeStock
Semaglutide Shows Potential for Significant CVD Prevention: Daily Dose

March 6th 2024

Global Obesity Rates Top One Billion, Quadrupling Among Youth from 1999-2022 / image credit watercolor globe: ©galany_p/stock.adobe.com
Global Obesity Rates Top One Billion, Quadrupling Among Youth from 1999-2022

March 1st 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.